Ford Robert B, Chairman and CEO of Abbott Laboratories ($ABT), made one open market purchase of company shares in the last year, totaling about $2 million. His most recent buy occurred on January 23, 2026. This activity ranks 312th among nearly 5,000 insiders by purchase value, surpassing the average of $1.46 million across 3.29 transactions per insider. Ford Robert B reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | F | Common shares without par value | 30308 | $116.26 | 522,664.0000 | 1,996,795,525 | 5.48% | 0.00% |
| Feb. 24, 2026 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | A | Option (right to buy) | 344066 | $0.00 | 344,066.0000 | 1,996,795,525 | 9999.99% | 0.02% |
| Feb. 24, 2026 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | A | Common shares without par value | 83464 | $0.00 | 552,972.0000 | 1,996,795,525 | 17.78% | 0.00% |
| Jan. 23, 2026 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | P | Common shares without par value | 18800 | $107.13 | 469,508.0000 | 1,996,795,525 | 4.17% | 0.00% |
| Feb. 28, 2025 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | F | Common shares without par value | 31651 | $135.87 | 450,708.0000 | 1,991,472,630 | 6.56% | 0.00% |
| Feb. 25, 2025 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | A | Option (right to buy) | 241706 | $0.00 | 241,706.0000 | 1,991,472,630 | 9999.99% | 0.01% |
| Feb. 25, 2025 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | A | Common shares without par value | 64897 | $0.00 | 482,359.0000 | 1,991,472,630 | 15.55% | 0.00% |
| Feb. 5, 2025 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | M | Option (right to buy) | 285388 | $0.00 | 0.0000 | 1,991,472,630 | 100.00% | 0.01% |
| Feb. 5, 2025 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | S | Common shares without par value | 285388 | $131.17 | 417,462.0000 | 1,991,472,630 | 40.60% | 0.01% |
| Feb. 5, 2025 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | M | Common shares without par value | 285388 | $38.40 | 702,850.0000 | 1,991,472,630 | 68.36% | 0.01% |
| Sept. 12, 2024 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | M | Option (right to buy) | 127436 | $0.00 | 0.0000 | 1,990,029,292 | 100.00% | 0.01% |
| Sept. 12, 2024 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | M | Option (right to buy) | 14243 | $0.00 | 0.0000 | 1,990,029,292 | 100.00% | 0.00% |
| Sept. 12, 2024 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | M | Common shares without par value | 14243 | $48.90 | 559,141.0000 | 1,990,029,292 | 2.61% | 0.00% |
| Sept. 12, 2024 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | M | Common shares without par value | 127436 | $47.00 | 544,898.0000 | 1,990,029,292 | 30.53% | 0.01% |
| Sept. 12, 2024 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | S | Common shares without par value | 80299 | $116.04 | 478,842.0000 | 1,990,029,292 | 14.36% | 0.00% |
| Sept. 12, 2024 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | S | Common shares without par value | 61380 | $116.90 | 417,462.0000 | 1,990,029,292 | 12.82% | 0.00% |
| Feb. 29, 2024 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | F | Common shares without par value | 31610 | $120.05 | 417,462.0000 | 1,987,883,852 | 7.04% | 0.00% |
| Feb. 21, 2024 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | A | Common shares without par value | 70332 | $0.00 | 449,072.0000 | 1,987,883,852 | 18.57% | 0.00% |
| Feb. 21, 2024 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | A | Option (right to buy) | 264293 | $0.00 | 264,293.0000 | 1,987,883,852 | 9999.99% | 0.01% |
| Feb. 28, 2023 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | F | Common shares without par value | 30742 | $99.77 | 378,740.0000 | 1,986,519,278 | 7.51% | 0.00% |
| Feb. 17, 2023 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | A | Common shares without par value | 70008 | $0.00 | 409,482.0000 | 1,986,519,278 | 20.62% | 0.00% |
| Feb. 17, 2023 | ABBOTT LABORATORIES | $ABT | Ford Robert B | CHAIRMAN AND CEO | A | Option (right to buy) | 276082 | $0.00 | 276,082.0000 | 1,986,519,278 | 9999.99% | 0.01% |